SL-401: An Encouraging Option for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

American Society of Hematology
4.4K
312 views

Transcript

The interactive transcript could not be loaded.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 6, 2016

Naveen Pemmaraju, MD, discusses early results from an ongoing trial of SL-401 in patients with the rare, aggressive malignancy blastic plasmacytoid dendritic cell neoplasm.

When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to